Ackland SP - Search Results

1

Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancer.

van Laar JA, Rustum YM, Ackland SP, van Groeningen CJ, Peters GJ. van Laar JA, et al. Among authors: ackland sp. Eur J Cancer. 1998 Feb;34(3):296-306. doi: 10.1016/s0959-8049(97)00366-3. Eur J Cancer. 1998. PMID: 9640213 Review.

2

Basis for effective combination cancer chemotherapy with antimetabolites.

Peters GJ, van der Wilt CL, van Moorsel CJ, Kroep JR, Bergman AM, Ackland SP. Peters GJ, et al. Among authors: ackland sp. Pharmacol Ther. 2000 Aug-Sep;87(2-3):227-53. doi: 10.1016/s0163-7258(00)00086-3. Pharmacol Ther. 2000. PMID: 11008002 Review.

3

Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells.

Temmink OH, Hoebe EK, van der Born K, Ackland SP, Fukushima M, Peters GJ. Temmink OH, et al. Among authors: ackland sp. Br J Cancer. 2007 Jan 29;96(2):231-40. doi: 10.1038/sj.bjc.6603549. Br J Cancer. 2007. PMID: 17242697 Free PMC article.

4

Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs.

Ackland SP, Peters GJ. Ackland SP, et al. Drug Resist Updat. 1999 Aug;2(4):205-214. doi: 10.1054/drup.1999.0089. Drug Resist Updat. 1999. PMID: 11504493

5

Thymidylate synthase inhibitors.

Ackland SP, Clarke SJ, Beale P, Peters GJ. Ackland SP, et al. Cancer Chemother Biol Response Modif. 2002;20:1-36. Cancer Chemother Biol Response Modif. 2002. PMID: 12703198 Review. No abstract available.

6

Thymidine phosphorylase in angiogenesis and drug resistance. Homology with platelet-derived endothelial cell growth factor.

Peters GJ, De Bruin M, Fukushima M, Van Triest B, Hoekman K, Pinedo HM, Ackland SP. Peters GJ, et al. Among authors: ackland sp. Adv Exp Med Biol. 2000;486:291-4. Adv Exp Med Biol. 2000. PMID: 11783503 Review. No abstract available.

7

Thymidylate synthase inhibitors.

Ackland SP, Beale P, Peters GJ. Ackland SP, et al. Cancer Chemother Biol Response Modif. 2003;21:1-28. doi: 10.1016/s0921-4410(03)21001-2. Cancer Chemother Biol Response Modif. 2003. PMID: 15338738 Review. No abstract available.

8

A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer.

Ackland SP, Jones M, Tu D, Simes J, Yuen J, Sargeant AM, Dhillon H, Goldberg RM, Abdi E, Shepherd L, Moore MJ. Ackland SP, et al. Br J Cancer. 2005 Nov 28;93(11):1236-43. doi: 10.1038/sj.bjc.6602841. Br J Cancer. 2005. PMID: 16265352 Free PMC article.

9

Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysis.

Garg MB, Lincz LF, Adler K, Scorgie FE, Ackland SP, Sakoff JA. Garg MB, et al. Among authors: ackland sp. Br J Cancer. 2012 Oct 23;107(9):1525-33. doi: 10.1038/bjc.2012.421. Epub 2012 Sep 18. Br J Cancer. 2012. PMID: 22990653 Free PMC article.

10

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

Talbot DC, Moiseyenko V, Van Belle S, O'Reilly SM, Alba Conejo E, Ackland S, Eisenberg P, Melnychuk D, Pienkowski T, Burger HU, Laws S, Osterwalder B. Talbot DC, et al. Br J Cancer. 2002 May 6;86(9):1367-72. doi: 10.1038/sj.bjc.6600261. Br J Cancer. 2002. PMID: 11986765 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page